More

Categories

Countries

Siponimod

TypeName: Business Offer
Category:
Offer Date:2019/09/04
Country: United States
Summary: Siponimod is a selective S1P1 and S1P5 agonist with EC50 of 0.39 nM and 0.98 nM, respectively. It has been approved by US FDA for the treatment of patients with active secondary progressive multiple sclerosis (SPMS).
https://www.bocsci.com/siponimod-cas-1230487-00-9-item-463380.html
Description:
OfferId: 5443
Name:Alex Brown
Telphone:
Email:[email protected]

Advertising

Danny Auto Glass
Dwell Christian Therapy & Training
Handyman Pros of Oceanside
Matt The Driveway Guy, LLC
Oxford Minibus & Coaches
PPC Locksmith
Virgin Islands Retreats
Categories
No Man flag